글로벌 양막대 증후군 시장 – 2030년까지의 산업 동향 및 예측

양막대 증후군 시장 분석 및 규모

글로벌 양막대 증후군 시장은 태아 영상 및 진단 기술의 발전으로 인해 상당한 성장을 경험했으며, 이는 글로벌 양막대 증후군 시장의 원동력 중 하나입니다. 그러나 ABS는 약 10,000명의 산아 중 1명에게 영향을 미치는 극히 드문 질환이라는 점에 유의하는 것이 중요합니다. 따라서 시장 규모는 ABS 사례의 유병률에 따라 영향을 받습니다.                   

Data Bridge Market Research는 2022년에 1억 1,412만 달러였던 글로벌 양막대 증후군 시장이 2030년까지 3억 3,412만 달러에 도달할 것으로 예상되며, 2023년에서 2030년까지의 예측 기간 동안 4.30%의 CAGR을 보일 것으로 분석했습니다. "양막 파열 시퀀스"는 산전 영상 및 진단의 발전으로 인해 글로벌 양막대 증후군 시장의 증상 유형 세그먼트를 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

양막대 증후군 시장 범위 및 세분화

시장 정의

양막대 증후군(ABS)은 정상적으로 발달하도록 의도된 장기의 파괴, 변형 및 기형을 포함한 다양한 선천적 이상으로 구성됩니다. 양막대 증후군은 증후군이 아닌 시퀀스라고 해야 하는데, ABS의 이상 패턴은 여러 원인에서 비롯될 수 있는 손상과 관련이 있는 반면, 증후군은 단일 원인에서 비롯된 것으로 알려진 선천적 이상 패턴을 말합니다(예: 터너 증후군은 XO 염색체 이상으로 인해 발생합니다). 마찬가지로 ABS는 양막 파열 시퀀스, ADAM 복합체(양막 변형/유착/절단), 양막대 붕괴 복합체, 선천적 수축대, 말단 횡단 결손 및 스트리터 이상이라는 여러 가지 이름을 가지고 있습니다.

글로벌 양막대 증후군 시장 동향

운전자

• 태아 영상 및 진단의 발전

산전 영상 및 진단 기술의 발전은 ABS 시장을 주도하는 데 중요한 역할을 했습니다. 고해상도 초음파, 자기공명영상 (MRI), 유전자 검사는 임신 중 ABS의 조기 발견 및 진단을 개선했습니다. 이러한 고급 영상 방식을 통해 의료 전문가는 태아의 사지나 장기를 압박하는 양막대와 같은 ABS 관련 합병증의 징후를 더 이른 단계에서 식별할 수 있습니다. 결과적으로 임산부와 의료 제공자는 산전 관리 및 잠재적 개입에 대한 정보에 입각한 결정을 내릴 수 있습니다. 이러한 조기 진단은 ABS 관련 의료 제품 및 서비스에 대한 수요 증가에 기여하여 시장 성장을 촉진합니다.

• 인식과 교육의 확대

A significant driver for the ABS market is the growing awareness and education about this rare congenital condition. Healthcare professionals, including obstetricians and pediatricians, have become increasingly aware of ABS and its potential impact on fetal development. Additionally, expectant parents are now more informed about the condition, thanks to improved access to medical information and prenatal resources. As a result, there is a greater likelihood of early diagnosis and timely interventions. The heightened awareness and education efforts have expanded the market for ABS-related products and services as more individuals seek appropriate medical care

• Innovations in Surgical Techniques

Innovations in surgical techniques have positively influenced the ABS market, particularly in addressing limb and organ deformities. Microsurgery, minimally invasive procedures, and advances in reconstructive techniques have improved surgical outcomes for individuals with ABS-related limb anomalies. These innovations not only enhance the effectiveness of surgical interventions but also contribute to shorter recovery times and improved quality of life for patients. Consequently, the demand for specialized surgical services for ABS has increased, fostering market growth

Opportunities

• Adoption of Telemedicine and Telehealth

The growing adoption of telemedicine and telehealth solutions presents an opportunity to expand access to medical consultations and support services for individuals with ABS, especially in remote or underserved areas. Telehealth platforms can facilitate consultations with specialized healthcare providers, offer guidance on prenatal care, and provide psychological support for affected individuals and their families. The convenience and accessibility of telemedicine can enhance the overall care experience for those with ABS

• Patient Advocacy and Support Groups

Patient advocacy organizations and support groups dedicated to ABS can play a vital role in advancing the market. These organizations advocate for increased awareness, fund research initiatives, and provide support services to individuals and families affected by ABS. Collaboration with patient advocacy groups can enhance patient care, provide valuable insights for research and development efforts, and foster a sense of community among those impacted by ABS

Restraints/Challenges

• High Cost of Treatment

The high cost associated with ABS-related treatment is a notable restraint, affecting both individuals and healthcare systems. Surgical procedures, ongoing medical care, and rehabilitative therapies can be financially burdensome for affected families. Insurance coverage for ABS-related treatments may also be limited or subject to restrictions. The high cost of treatment can lead to delays in seeking medical care and interventions, particularly for individuals without adequate financial resources or insurance coverage

• Access to Specialized Care

Access to specialized medical care for ABS-related interventions may be limited in certain regions. This challenge leads to disparities in treatment outcomes, with some individuals facing difficulties in accessing expert surgical and medical services. Addressing disparities in care and improving access to specialized healthcare providers remains a challenge for the ABS market

This global amniotic band syndrome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global amniotic band syndrome market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth

Recent Development

• In December 20202, According to the National Library of Medicine, the estimated incidence of amniotic band syndrome ranged between 1 in 1000 to 1 in 15000 live births and 1 in 70 stillbirths

Global Amniotic Band Syndrome Market Scope

The global amniotic band syndrome market is segmented on the basis of symptoms type, diagnosis type, therapy type, treatment type, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Symptoms Type

• Amnion Rupture Sequence
• Amniotic Deformity
• Adhesions
• Mutilations (ADAM) Complex
• Streeter Dysplasia
• Others

Diagnosis Type

• Targeted Ultrasound
• Amniocentesis
• Foetal echocardiogram
• Others

Therapy Type

• Supportive Therapies
• Physical Therapy
• Occupational Therapy
• Others

Treatment Type

• Prosthesis
• Foetal Surgery
• Reconstructive Surgery
• Others

End-Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Global Amniotic Band Syndrome Market Regional Analysis/Insights

The global amniotic band syndrome market is analyzed and market size insights and trends are provided by symptoms type, diagnosis type, therapy type, treatment type, end-users and distribution channel as referenced above.

The countries covered in the global amniotic band syndrome market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the global amniotic band syndrome market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increase in the expenditure for research and development proficiencies, increasing government’s initiatives and improved health care infrastructure in various countries.

Asia-Pacific on the other hand, is projected to exhibit the highest growth rate in the global amniotic band syndrome market during the forecast period of 2023 to 2030 owing to the increasing government expenditure on the healthcare sector and rising technological advancements and initiatives by the government.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Amniotic Band Syndrome Market Share Analysis

The global amniotic band syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to global amniotic band syndrome market.

Some of the major players operating in the global amniotic band syndrome market are:

• GSK plc. (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Novartis AG (Switzerland)
• Astrazeneca (U.S.)
• Pfizer Inc. (U.S.)
• Bristol-Myers Squibb Company (U.S.)
• Sanofi (U.S.)
• Amgen Inc. (U.S.)
• Daiichi Sankyo Company Limited (Japan)
• AB Sciences (France)
• Eisai Co., Ltd (Japan)
• Genentech Inc. (U.S)
• Merck & Co., Inc. (U.S.)

SKU-50354